We revealed that exosomes loaded with si-PDGFRβ, which targeted ZEB1, inhibited glioma cells' invasion, proliferation, and migration via inhibiting the PI3K/Akt/EZH2 pathway. Here, PDGFRB is linked to central nervous system cancer.